SEC Form 4 · accession 0001171843-15-004270
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sylvia Cheung
Officer — Chief Financial Officer
Period of report
Jul 31, 2015
Accepted (ET)
Aug 3, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2015 | M | 5,000 | $12.61 | A | 24,825 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.61 | Jul 31, 2015 | M | 5,000 | A | — | Aug 1, 2015 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The stock options vested in four equal annual installments beginning August 1, 2006.